SWK/SWKH

$17.52

-0.96%
-
1D1W1MYTD1YMAX

About SWK

SWK Holdings Corporation is engaged in specialty finance and asset management business. The Company’s segments include Finance Receivables and Pharmaceutical Development. Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Its Pharmaceutical Development segment operates through its subsidiary Enteris BioPharma, Inc. (Enteris). Enteris is a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its oral drug delivery technologies, the Peptelligence platform.

Ticker

SWKH

Sector

Financials

Trading on

NASDAQ

Industry

Consumer Financial Services

CEO

Joe Staggs

Employees

23

Headquarters

Dallas, United States

SWK Metrics

BasicAdvanced
$221.07M
Market cap
14.15
P/E ratio
$1.25
EPS
0.33
Beta
-
Dividend rate
$221.07M
0.32591
$18.75
$15.26
11.33K
3.009
15.387
15.387
14.454
5.01%
5.67%
5.1%
14.152
5.855
0.789
0.807
15.362
-8.98%
19.28%
0.94%
45.71%

What the Analysts think about SWK

Analyst Ratings

Majority rating from 2 analysts.
Buy

Price Targets

Average projection from 2 analysts.
36.99% upside
High $26.00
Low $22.00
$17.52
Current price
$24.00
Average price target

SWK Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
28.57% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$9.8M
10.11%
Net income
$2.8M
-36.36%
Profit margin
28.57%
-42.2%

SWK Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 24.59%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.36
$0.31
$0.36
$0.23
-
Expected
$0.35
$0.38
$0.35
$0.31
$0.00
Surprise
2.86%
-17.33%
4.35%
-24.59%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for SWK stock?

SWK (SWKH) has a market cap of $221.07M as of April 23, 2024.

What is the P/E ratio for SWK stock?

The price to earnings (P/E) ratio for SWK (SWKH) stock is 14.15 as of April 23, 2024.

Does SWK stock pay dividends?

No, SWK (SWKH) stock does not pay dividends to its shareholders as of April 23, 2024.

When is the next SWK dividend payment date?

SWK (SWKH) stock does not pay dividends to its shareholders.

What is the beta indicator for SWK?

SWK (SWKH) has a beta rating of 0.33. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the SWK stock price target?

The target price for SWK (SWKH) stock is $24, which is 39.13% above the current price of $17.25. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell SWK stock

Buy or sell SWK stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing